Literature DB >> 476705

Association between steroid hormone receptor status and disease-free interval in breast cancer.

J C Allegra, M E Lippman, R Simon, E B Thompson, A Barlock, L Green, K K Huff, H M Do, S C Aitken, R Warren.   

Abstract

The possibility of an association between steroid hormone receptor status and disease-free interval was examined in 292 patients with breast cancer. Estrogen receptor positivity was associated with a prolonged disease-free interval. This association was independent of age, menopausal status, tumor size, or nodal status. There was no association between the presence or absence of progesterone, androgen, or glucocorticoid receptor and disease-free interval.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476705

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  28 in total

1.  Prognostic significance of steroid hormone receptors and histopathological characterization of human breast cancer.

Authors:  A Reiner; R Kolb; G Reiner; R Jakesz; M Schemper; J Spona
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.

Authors:  T E Kute; H B Muss; M Hopkins; R Marshall; D Case; L Kammire
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

3.  Disease-free interval and estrogen receptor activity in tumor tissue of patients with primary breast cancer: analysis after long-term follow-up.

Authors:  J M Raemaekers; L V Beex; A J Koenders; G F Pieters; A G Smals; T J Benraad; P W Kloppenborg
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 4.  Practical breast carcinoma cell kinetics: review and update.

Authors:  J S Meyer; R W McDivitt; K R Stone; M U Prey; W C Bauer
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

5.  Tumor nuclear grade, estrogen receptor, and progesterone receptor: their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer.

Authors:  B Fisher; E R Fisher; C Redmond; A Brown
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

6.  Estrogen receptor status of breast cancer in Ontario.

Authors:  G E McKeown-Eyssen; I Rogers-Melamed; E A Clarke
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

7.  Estrogen and progesterone receptor profile patterns in primary breast cancer.

Authors:  S M Thorpe; C Rose; B V Pedersen; B B Rasmussen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

8.  Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate.

Authors:  P M Martin; M Cotard; J P Mialot; F André; J P Raynaud
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

9.  The clinical course of lung metastases from breast cancer.

Authors:  O K Schlappack; M Baur; G Steger; C Dittrich; K Moser
Journal:  Klin Wochenschr       Date:  1988-09-01

10.  Prognostic value of estrogen and progesterone receptors in primary breast cancer.

Authors:  S Saez; F Cheix; B Asselain
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.